OMV Vaccines and the Role of TLR Agonists in Immune Response
Outer Membrane Vesicles (OMVs) are bacterial nanoparticles that are spontaneously released during growth both in vitro and in vivo by Gram-negative bacteria. They are spherical, bilayered membrane nanostructures that contain many components found within the external surface of the parent bacterium....
Main Authors: | Francesca Mancini, Omar Rossi, Francesca Necchi, Francesca Micoli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/12/4416 |
Similar Items
-
GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
by: Francesca Micoli, et al.
Published: (2020-09-01) -
Towards a Four-Component GMMA-Based Vaccine against <i>Shigella</i>
by: Francesca Micoli, et al.
Published: (2022-02-01) -
Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine Potency
by: Elena Palmieri, et al.
Published: (2021-03-01) -
Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component <i>Shigella</i> GMMA-Based Vaccines
by: Danielle Carson, et al.
Published: (2021-06-01) -
Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against <i>Shigella</i>
by: Francesca Mancini, et al.
Published: (2023-02-01)